. 2017 Jul 19;11(7):e0005796. doi: 10.1371/journal.pntd.0005796

Table 3. Characteristics of patients with progressive CCC.

	CCC(P-WD/MD) (n = 12)	CCC(P-MOD/SD) (n = 14)	OR	p-value
Age (years)	67.33±11.66	58.14±9.78	-	0.043^a
Progression defined by EKG	Yes– 11 (91,67%)	Yes– 4 (28,57%)	27.5	0.0017^b
Progression defined by EKG	No– 1 (8,33%)	No– 10 (71,43%)	27.5	0.0017^b
Progression defined by ECHO	Yes– 2 (16,66%)	Yes– 13 (92,86%)	0.015	0.0002^b
Progression defined by ECHO	No– 10 (83,34%)	No– 1 (7,14%)	0.015	0.0002^b
LVEF variation (percentage points)	-3.25±7.82	-15.29±12.79	-	0.0024^c
Time to disease progression (years)	5.17±2.21	6.73±3.37	-	0.16^a

^a p values were calculated using unpaired t-test

^b p values were calculated using Fisher’s exact test

^c p values were calculated using Mann-Whitney test. The values are represented by mean ± standard deviation. The characteristics were represented as mean ± SD for Age, LVEF variation and time to disease progression, while progression defined by EKG or ECHO were represented as absolute numbers and percentage.